David Badawi - 19 Feb 2026 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role: Chief Technology Officer, Director
Signature: /s/Jeremy Hayden, Attorney-in-Fact for David Badawi
Issuer symbol: SGHT
Transactions as of: 19 Feb 2026
Net transactions value: +$4,892
Form type: 4
Filing time: 23 Feb 2026, 16:28:55 UTC
Previous filing: 05 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Badawi David	Chief Technology Officer, Director	C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK	/s/Jeremy Hayden, Attorney-in-Fact for David Badawi	23 Feb 2026	0001870825

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGHT	Common Stock	Options Exercise	$4,892	+21,270	+1.1%	$0.2300	1,998,458	19 Feb 2026	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SGHT	Stock Option (Right to Buy)	Options Exercise	$0	-21,270	-100%	$0.000000	0	19 Feb 2026	Common Stock	21,270	$0.2300	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the exercise of stock options ("Options") awarded to the Reporting Person under the Issuer's equity incentive plan.
F2	Includes (i) 1,795,520 shares of common stock, and (ii) 202,938 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested.
F3	The grant of Options made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options became fully vested and exercisable on January 1, 2020.